ArticleClinical rheumatology2026
Non-linear association of admission platelet-to-lymphocyte ratio with 28- and 90-day mortality in critically ill patients with rheumatoid arthritis: a retrospective cohort study.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCritically ill patients with rheumatoid arthritis (RA) have high short-term mortality. The platelet-to-lymphocyte ratio (PLR) reflects RA inflammatory activity. We evaluated whether admission PLR is associated with 28- and 90-day mortality in critically ill patients with RA.
methodsRA patients were identified from the MIMIC-IV database. Restricted cubic spline (RCS) Cox models characterized the PLR-mortality association and defined a log PLR threshold. Patients were stratified into low, middle, and high PLR groups using this threshold with a ± 0.3 margin (δ). Cumulative incidence of death was assessed using the Kaplan-Meier method. Piecewise Cox models were constructed with incremental adjustment. Subgroup analyses tested the consistency of PLR's effect across different strata.
resultsAmong 989 patients, 28- and 90-day mortality were 16.4% and 23.5%. RCS analysis showed a U-shaped association, with the lowest risk at log PLR = 4.725 and higher hazards toward both extremes. In piecewise Cox models, each + 1 log PLR was associated with lower mortality in the low PLR segment (28-day hazard ratio (HR) 0.59; 90-day HR 0.61) but higher risk in the high PLR segment (28-day HR 1.72; 90-day HR 1.67). Associations persisted after multivariable adjustment, with consistent subgroup trends.
conclusionsAdmission PLR is a significant prognostic marker in critically ill RA, demonstrating a U-shaped relationship with 28- and 90-day mortality. Both abnormally low and high PLR values were associated with higher mortality. Key Points • Admission PLR shows a U-shaped, independent association with 28- and 90-day mortality, with the lowest risk at log PLR 4.725 (~ PLR ≈112). • Threshold groups (PLR < ~ 84, 84 -153) and piecewise Cox models reveal decreasing risk below and increasing risk above the cutoff, persisting after multivariable adjustment. • Effects remain after multivariable adjustment and are consistent across clinical subgroups. • As a routine CBC metric, PLR enables simple early ICU risk stratification for RA, highlighting excess risk at both extremes.
Indexed as
Identifiers
41366182What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.